Endomyocardial biopsy in Henoch-Schönlein purpura

Impact of preprocedural white blood cell count on long term mortality after percutaneous coronary intervention: insights from the EPIC, EPILOG, and EPISTENT trials.

Heart (British Cardiac Society)·2003

The platelet function dose-response to abciximab during percutaneous coronary revascularization is variable.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2001

Differential effects of citrate versus PPACK anticoagulation on measured platelet inhibition by abciximab, eptifibatide and tirofiban.

Journal of thrombosis and thrombolysis·2001

Intracoronary administration of recombinant human vascular endothelial growth factor to patients with coronary artery disease.

American heart journal·2001

Leukocyte-platelet aggregation, platelet surface P-selectin, and platelet surface glycoprotein IIIa after percutaneous coronary intervention: Effects of dalteparin or unfractionated heparin in combination with abciximab.

American heart journal·2001

Low molecular weight heparin therapy for percutaneous coronary intervention: a practice in evolution.

Journal of thrombosis and thrombolysis·2001

Incidence, medical therapy, and outcomes in heart failure with improved ejection fraction across guideline definitions.

American heart journal·2026

Clinical and Economic Outcomes in Diagnostic-Naïve Medicare Fee-for-Service Beneficiaries Managed with Alert-Based Ambulatory Cardiac Monitors: the CAMELOT-ALERT Study.

American heart journal·2026

Clinical outcomes associated with recurrent compared to first-time myocardial infarction.

American heart journal·2026

Age-specific coronary outcomes in subacute Kawasaki disease.

American heart journal·2026

Cardiorespiratory Fitness in Children with Surgically Corrected Congenital Heart Disease: Exercise Testing Profiles and Biventricular Function.

American heart journal·2026

High-Sensitivity HEART Pathway One-and-Done Troponin Strategy is Safe and Effective.

American heart journal·2026

From Structural Resolution to Functional Elucidation: Research Progress of GPR158 as a Target for Antidepressant Drug Development.

Current neuropharmacology·2026

Psychedelic therapy without durable effects: A review and re-evaluation of controlled studies between 1965 and 1977.

Journal of psychopharmacology (Oxford, England)·2026

Structural basis of β-arrestin coupling and transducer selectivity in PAC1R.

Acta pharmacologica Sinica·2026

Behind the photographs: Close relations between German pharmacologists and the British Pharmacological Society in the 1930s observed through the diary of Wolfgang Heubner.

British journal of pharmacology·2026

Posttherapy [18F]FDOPA PET Findings in an Anaplastic Pleomorphic Xanthoastrocytoma With a BRAF V600E Mutation.

Clinical nuclear medicine·2026

Identification and validation of central amygdala FGFR1 as a therapeutic target for alcohol use disorder using single-nucleus sequencing in rats.

Nature communications·2026

Related Experiment Videos

Endomyocardial biopsy in Henoch-Schönlein purpura

Related Concept Videos

Impact of preprocedural white blood cell count on long term mortality after percutaneous coronary intervention: insights from the EPIC, EPILOG, and EPISTENT trials.

The platelet function dose-response to abciximab during percutaneous coronary revascularization is variable.

Differential effects of citrate versus PPACK anticoagulation on measured platelet inhibition by abciximab, eptifibatide and tirofiban.

Intracoronary administration of recombinant human vascular endothelial growth factor to patients with coronary artery disease.

Leukocyte-platelet aggregation, platelet surface P-selectin, and platelet surface glycoprotein IIIa after percutaneous coronary intervention: Effects of dalteparin or unfractionated heparin in combination with abciximab.

Low molecular weight heparin therapy for percutaneous coronary intervention: a practice in evolution.

Incidence, medical therapy, and outcomes in heart failure with improved ejection fraction across guideline definitions.

Clinical and Economic Outcomes in Diagnostic-Naïve Medicare Fee-for-Service Beneficiaries Managed with Alert-Based Ambulatory Cardiac Monitors: the CAMELOT-ALERT Study.

Clinical outcomes associated with recurrent compared to first-time myocardial infarction.

Age-specific coronary outcomes in subacute Kawasaki disease.

Cardiorespiratory Fitness in Children with Surgically Corrected Congenital Heart Disease: Exercise Testing Profiles and Biventricular Function.

High-Sensitivity HEART Pathway One-and-Done Troponin Strategy is Safe and Effective.

From Structural Resolution to Functional Elucidation: Research Progress of GPR158 as a Target for Antidepressant Drug Development.

Psychedelic therapy without durable effects: A review and re-evaluation of controlled studies between 1965 and 1977.

Structural basis of β-arrestin coupling and transducer selectivity in PAC1R.

Behind the photographs: Close relations between German pharmacologists and the British Pharmacological Society in the 1930s observed through the diary of Wolfgang Heubner.

Posttherapy [18F]FDOPA PET Findings in an Anaplastic Pleomorphic Xanthoastrocytoma With a BRAF V600E Mutation.

Identification and validation of central amygdala FGFR1 as a therapeutic target for alcohol use disorder using single-nucleus sequencing in rats.

Related Experiment Videos

Endomyocardial biopsy in Henoch-Schönlein purpura

Related Concept Videos

Related Articles